( February 4, 2025, 8:29 AM EST) -- SAN FRANCISCO — A Ninth Circuit U.S. Court of Appeals panel affirmed an award of more than $7.9 million in attorney fees and expenses for class counsel in one of several related single-state class lawsuits over the labeling of a glucosamine and chondroitin product, finding that the evidence supported the trial court’s determination that fees were related to the class’s success and the defendant failed to undermine class counsel’s representation that all work performed for the other cases was excluded from its calculations....